BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2051508)

  • 1. Mass poisoning by sodium arsenite.
    Roses OE; García Fernández JC; Villaamil EC; Camussa N; Minetti SA; Martínez de Marco M; Quiroga PN; Rattay P; Sassone A; Valle G
    J Toxicol Clin Toxicol; 1991; 29(2):209-13. PubMed ID: 2051508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of the body burden of arsenic in a child fatally poisoned by arsenite weedkiller.
    Saady JJ; Blanke RV; Poklis A
    J Anal Toxicol; 1989; 13(5):310-2. PubMed ID: 2615344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Massive arsenic poisoning--effect of hemodialysis and dimercaprol on arsenic kinetics.
    Mathieu D; Mathieu-Nolf M; Germain-Alonso M; Neviere R; Furon D; Wattel F
    Intensive Care Med; 1992; 18(1):47-50. PubMed ID: 1578049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxipathic hepatitis due to Fowler's solution; a case treated with dimercaprol.
    WADE HJ; FRAZER ES
    Lancet; 1953 Feb; 1(6754):269-71. PubMed ID: 13012048
    [No Abstract]   [Full Text] [Related]  

  • 5. DMSA, DMPS, and DMPA--as arsenic antidotes.
    Aposhian HV; Carter DE; Hoover TD; Hsu CA; Maiorino RM; Stine E
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S58-70. PubMed ID: 6327446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic concentrations in tissues and body fluids of dogs on chronic low-level dietary sodium arsenite.
    Neiger RD; Osweiler GD
    J Vet Diagn Invest; 1992 Jul; 4(3):334-7. PubMed ID: 1515496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Excretion of arsenic in human urine after treatment with BAL].
    Geldmacher-von Mallinck ; Schütz W; Pétenyi M; Wolf R
    Beitr Gerichtl Med; 1973; 30():108-16. PubMed ID: 4702736
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative acute systemic toxicity of sodium arsenite and dichloro(2-chlorovinyl)arsine in rabbits.
    Inns RH; Bright JE; Marrs TC
    Toxicology; 1988 Oct; 51(2-3):213-22. PubMed ID: 3176029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cutaneous pigmentation in spots; arsenical poisoning? Sensitivity of the skin to sodium arsenite].
    CARPENTIER E
    Arch Belg Dermatol Syphiligr; 1951 Sep; 7(3):154-5. PubMed ID: 14915515
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical manifestation and influential factors in patients with acute arsenic poisoning].
    Liu WW; Yang ZQ; Zhang C; Zhang YL; Jiang WZ; Wu YX; Liu YM; Gu LC
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Nov; 26(11):645-8. PubMed ID: 19467180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An explosive reaction following the simultaneous administration of sodium arsenite and dithioglycerol (BAL) in vivo.
    KOPPANYI T; SPERLING F
    Anat Rec; 1946 Dec; 96(4):501. PubMed ID: 20341381
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyanide and arsenic poisoning by intravenous injection.
    DiNapoli J; Hall AH; Drake R; Rumack BH
    Ann Emerg Med; 1989 Mar; 18(3):308-11. PubMed ID: 2538098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute arsenic poisoning].
    Johansen JB; Abildtrup A; Ebbehøj NE; Kristensen SR; Eshøj O
    Ugeskr Laeger; 1996 Jul; 158(29):4201-2. PubMed ID: 8701539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adult respiratory distress syndrome and arsenic poisoning caused by Fowler's solution].
    Fernández-Quero Bonilla L; Martínez-Arcos SA
    Rev Esp Anestesiol Reanim; 1985; 32(4):194-5. PubMed ID: 4048587
    [No Abstract]   [Full Text] [Related]  

  • 15. Central and autonomic effects following the combined administration of sodium arsenite and 2,3-dimercaptopropanol (BAL).
    KOPPANYI T; SPERLING F
    J Pharmacol Exp Ther; 1947 Apr; 89(4):350-5. PubMed ID: 20295515
    [No Abstract]   [Full Text] [Related]  

  • 16. Massive acute arsenic poisoning.
    Jolliffe DM; Budd AJ; Gwilt DJ
    Anaesthesia; 1991 Apr; 46(4):288-90. PubMed ID: 2024748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and disposition of arsenic species from oral dosing with sodium arsenite in neonatal CD-1 mice. IV. Toxicokinetics following gavage administration and lactational transfer.
    Twaddle NC; Vanlandingham M; Beland FA; Fisher JW; Doerge DR
    Food Chem Toxicol; 2019 Jan; 123():28-41. PubMed ID: 30342114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical isomers of 2,3-dimercapto-1-propanesulfonate: antidotal activity, in vitro and in vivo, against sodium arsenite.
    Hsu CA; Aposhian HV; Heydolph S; Parr W
    J Pharmacol Exp Ther; 1983 Feb; 224(2):314-8. PubMed ID: 6687396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dimercaptropropanol preparations in therapy of arsenic and heavy metal poisoning].
    MOSIG A
    Pharmazie; 1953 May; 8(5):403-5. PubMed ID: 13088281
    [No Abstract]   [Full Text] [Related]  

  • 20. Arsenic toxicology: five questions.
    Aposhian HV; Aposhian MM
    Chem Res Toxicol; 2006 Jan; 19(1):1-15. PubMed ID: 16411650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.